35
1
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T72621 | GCGR antagonist 2 | ||
GCGR Antagonist 2, a Furan-2-carbohydrazide, serves as an orally active antagonist of the glucagon receptor. It exhibits affinity for the human glucagon receptor (hGluR) with a dissociation constant (Kd) of 2.3 nM and de... | |||
TQ0124 | BETP | Glucagon Receptor | |
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor). | |||
T7364 | NNC-0640 | Glucagon Receptor | |
NNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM. | |||
T8748 | Exendin-4 acetate | Glucagon Receptor | |
Exendin-4 acetate is a 39 amino acid peptide.Exendin-4 acetate is a long-acting GLP-1 receptor agonist(IC50 = 3.22 nM). | |||
T19850 | Semaglutide | Glucagon Receptor | |
Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor). | |||
T11845 | LGD-6972 | Glucagon Receptor | |
LGD-6972 is an antagonist of glucagon receptor. | |||
TP2252 | GLP-1 (9-36) amide | Glucagon Receptor | |
antagonist at the human GLP-1 receptor | |||
T9579 | GLP-1 receptor agonist 9 | Glucagon Receptor | |
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist. | |||
T3422 | GRA Ex-25 | GRA-Ex-25 | Glucagon Receptor |
GRA Ex-25 (GRA-Ex-25) is an inhibitor of glucagon receptor. | |||
T3967 | Exendin-4 | Exenatide,Exenatide Acetate | Glucagon Receptor |
Exendin-4 (Exenatide) is a glucagon-like peptide-1 receptor (GLP-1) agonist (IC50: 3.22 nM). Exenatide is a 39 amino acid peptide. Compared to GLP-1, exenatide has a longer half-life of 2.4 hours. | |||
TP1039 | Secretin (33-59), rat | Secretin (rat) | Glucagon Receptor |
Secretin (33-59), rat (Secretin (rat)) is a classical hormone in the gastrointestinal system and a neuropeptide. | |||
TP1469 | Lixisenatide acetate (320367-13-3 free base) | Lixisenatide acetate | Glucagon Receptor |
Lixisenatide acetate is a receptor agonist similar to glucagon-like peptide-1 (glp-1) for the treatment of type 2 diabetes mellitus (T2DM). | |||
T6876 | Liraglutide | Liraglutidum,Victoza,Liraglutida,NN2211 | Glucagon Receptor |
Liraglutide (Liraglutida) is a long-acting GLP-1 receptor agonist. | |||
TP2100 | Avexitide | Exendin-3 (9-39) amide,Exendin (9-39) | Glucagon Receptor |
Avexitide (Exendin-3 (9-39) amide) (Exendin (9-39)) is a specific and competitive antagonist of glucagon-like peptide-1 (GLP-1) receptor. | |||
TQ0239 | PF-06291874 | Glucagon receptor antagonists-4 | Glucagon Receptor |
PF-06291874 (Glucagon receptor antagonists-4) (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor. | |||
TP1376 | GLP-1(7-37) acetate(106612-94-6 free base) | GLP-1(7-37) acetate | Others , Glucagon Receptor |
Glp-1(7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion. | |||
T15389L | Glucagon (1-29), bovine, human, porcine hydrochloride | Porcine glucagon hydrochloride,Glucagon hydrochloride | Glucocorticoid Receptor , Glucagon Receptor |
Glucagon (1-29), bovine, human, porcine hydrochloride is a peptide hormone, produced by pancreatic α-cells. It activates HNF4α and increases HNF4α phosphorylation. Glucagon (1-29), bovine, human, porcine hydrochloride(Po... | |||
T60047 | V-0219 | Glucagon Receptor | |
V-0219 is a positive allosteric modulator of GLP-1 and can be used in studies about obesity-associated diabetes. | |||
T3984 | GLP-1(7-36), amide | MKC 253,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide | Glucagon Receptor |
GLP-1(7-36), amide (MKC 253) is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic effects by potentiating glucose-... | |||
T76279 | Retatrutide | LY3437943 | Glucagon Receptor |
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide ... | |||
T76279L1 | Retatrutide sodium salt | Retatrutide sodium salt(2381089-83-2 free base),LY3437943 sodium salt | Glucagon Receptor |
Retatrutide sodium salt is a potent triple agonist peptide for glucagon receptor (GCGR), glucose-dependent proinsulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R) Retatrutide sodium s... | |||
T78097L | Mazdutide acetate(2259884-03-0 free base) | Mazdutide acetate(2259884-03-0 free base),OXM-3 acetate,LY-3305677 acetate,IBI-362 acetate | Glucagon Receptor |
Mazdutide acetate is a potent co-agonist of glucagon-like peptide (GLP-1R) and glucagon receptor (GCGR), a gastrin-regulating hormone analog.Mazdutide acetate stimulates insulin secretion from mouse pancreatic islets, an... | |||
T24620 | PF-06372222 | PF-0637222,PF0637222,PF 0637222 | |
PF-06372222 is a small-molecule negative allosteric modulator of the glucagon receptor (GCGR). PF-06372222 is also an antagonist for glucagon-like peptide-1 receptor GLP-1R, which inhibits glucagon secretion and glucose... | |||
T76668 | FC382K10W15 TFA | ||
FC382K10W15 TFA, a glucagon analogue and GLP-1R/GCGR agonist, holds promise for research in type 2 diabetes [1]. | |||
T76876 | Volagidemab | ||
Volagidemab, a monoclonal antibody (mAb) that antagonizes the glucagon receptor (GCGR), is utilized in researching Type 1 Diabetes (T1D) [1] [2]. | |||
T76279L | Retatrutide TFA | ||
Retatrutide (LY3437943) TFA is a triple agonist peptide targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Demonstrating i... | |||
T80084 | Retatrutide acetate | LY3437943 acetate | |
Retatrutide acetate (LY3437943) is a peptide that serves as a triple agonist for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). ... | |||
T78097 | Mazdutide | IBI-362,LY-3305677,OXM-3 | |
Mazdutide (IBI-362; LY-3305677), a synthetic oxyntomodulin analog, serves as a glucagon-like peptide-1 (GLP-1R)/glucagon receptor (GCGR) co-agonist. Demonstrating safety and tolerability, Mazdutide is utilized in obesity... | |||
T74421 | Pemvidutide | ||
Pemvidutide, a dual GLP-1R/GCGR agonist, significantly lowers body weight, liver fat, and serum lipids, holding promise for non-alcoholic steatohepatitis (NASH) and obesity research [1]. | |||
T76862 | Crotedumab | ||
Crotedumab (REGN1193), a fully human IgG4 monoclonal antibody, selectively binds to and inhibits the glucagon receptor (GCGR) with a dissociation constant (K D) of 0.1 nM, making it a potent candidate for diabetes resear... | |||
T78658 | Pemvidutide TFA | ||
Pemvidutide (TFA), a GLP-1R/GCGR dual agonist, effectively reduces body weight, liver fat, and serum lipid levels, and is utilized in research on non-alcoholic steatohepatitis (NASH) and obesity [1]. | |||
T76328 | Oxyntomodulin (swine) | ||
Oxyntomodulin (swine), a peptide hormone secreted from the gastrointestinal tract after meals, serves as a dual agonist for the GLP-1 receptor (GLP-1R) and glucagon receptor (GCGR). It plays a critical role in appetite s... | |||
T80079 | Mazdutide TFA | LY-3305677 TFA,IBI-362 TFA,OXM-3 TFA | |
Mazdutide (IBI-362; LY-3305677) TFA is a dual agonist for the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR), also recognized as a long-acting synthetic oxyntomodulin analog. It demonstrates a... | |||
T37223 | Glucagon Receptor Antagonist I | ||
Glucagon receptor antagonist I is a competitive antagonist of the glucagon receptor (GCGR; IC50 = 181 nM). It blocks glucagon-induced glycogenolysis in primary human hepatocytes and isolated liver. Glucagon receptor anta... | |||
T36380 | GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt) | ||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3896 | Shanzhiside methyl ester | Glucagon Receptor | |
Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01383 | GCGR Protein, Human, Recombinant (His & Myc) | Human | HEK293 |
G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and g... | |||
TMPH-02675 | GCGR Protein, Mouse, Recombinant (GST) | Mouse | E. coli |
G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and g... | |||
TMPH-01382 | GCGR Protein, Human, Recombinant (E. coli, His & Myc) | Human | E. coli |
G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis. Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and g... |